# Evaluation of LDL Cholesterol in Patients Switched From 10 to 5 Milligrams of Zetia (Ezetimibe)

> **NCT00762229** · NA · COMPLETED · sponsor: **Bronx VA Medical Center** · enrollment: 39 (actual)

## Conditions studied

- Hypercholesterolemia

## Interventions

- **DRUG:** Ezetimibe 10 mg
- **DRUG:** Ezetimibe 5 mg

## Key facts

- **NCT ID:** NCT00762229
- **Lead sponsor:** Bronx VA Medical Center
- **Sponsor class:** FED
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2008-09
- **Final completion:** 2008-09
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2013-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00762229

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00762229, "Evaluation of LDL Cholesterol in Patients Switched From 10 to 5 Milligrams of Zetia (Ezetimibe)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00762229. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*